Details of children at time of first BAL and of the whole group
| Parameters | First visit(N = 24) | Total visits(N = 27) |
|---|---|---|
| C/T/S, cephalosporin/trimethoprim/sulfamethoxazole. | ||
| No of subjects | 24 | 24 |
| Median (IQR) age at first study | 1.58 (1.07–2.75) | 1.58 (1.12–2.77) |
| Sex | 12M (50%) | 14M (52%) |
| Genotype | ||
| Homozygote | 17 (70.8%) | 19 (70.3%) |
| Heterozygote | 7 | 8 |
| Compound heterozygote (not F508) | 1 | 1 |
| No of visits | 27 | 27 |
| No of children with repeat visits | 3 | 3 |
| Microbiology at time of visit | ||
| No pathogen | 12 (48%) | 13 (48%) |
| Mixed oral flora | 3 (12%) | 3 (12%) |
| A fumigatus | 1 (4%) | 1 (4%) |
| S aureus | 3 (12%) | 3 (12%) |
| H influenzae | 1 (4%) | 2 (8%) |
| P aeruginosa | 4 (16.7%) | 4 (15%) |
| Enterobacter sp | 2 (8%) | 2 (8%) |
| C albicans | 1 (4%) | 1 (4%) |
| Other | 3 (12%) | 3 (12%) |
| Treatments at time of BAL | ||
| No antibiotics | 6 (22.2%) | |
| Amoxycillin/clavulanate | 18 (66.7%) | |
| C/T/S | 3 (11.1%) | |